GlassScriptPhysician profile
Adrian Mzee Smith
NPI 1538375076
$875.31
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.62 · 2022: $28.30 · 2023: $24.97 · 2024: $595 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $349.79 | 2024 | Identiti, Aspida |
| Medtronic, INC. | $112.72 | 2024-2025 | Stealthstation S8 Platform |
| Ethicon US, LLC | $69.89 | 2024-2025 | Dermabond, Vistaseal, Dermabond Prineo |
| Stryker Corporation | $68.97 | 2022-2025 | N/A |
| Globus Medical, INC. | $34.35 | 2025 | Vyrsa V1 |
| Integra Lifesciences Corporation | $30.73 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Amgen INC. | $27.33 | 2024 | Evenity, Prolia |
| Siemens Medical Solutions USA, INC. | $26.56 | 2025 | |
| Chiesi USA, INC. | $26.15 | 2024 | Cleviprex |
| Abbvie INC. | $24.97 | 2023 | Botox, Ubrelvy |
| Vertex Pharmaceuticals Incorporated | $20.82 | 2025 | |
| Nevro Corp. | $18.23 | 2024 | Senza |
| Depuy Synthes Sales INC. | $17.00 | 2024 | Vivigen Mis Delivery System, Sentio |
| Mimedx Group, INC. | $16.44 | 2025 | |
| Zimmer Biomet Holdings, INC. | $15.74 | 2025 | 1.5mm System - Craniocurve (Tm) Mesh, Htr-Pekk, Mimix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $15.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.